Diamyd Medical (Sweden) Today
| DMYD-B Stock | SEK 9.80 0.01 0.10% |
Performance6 of 100
| Odds Of DistressLess than 40
|
Diamyd Medical is trading at 9.80 as of the 20th of April 2024, a -0.1 percent down since the beginning of the trading day. The stock's open price was 9.81. Diamyd Medical has about a 40 percent probability of financial distress in the next few years of operation and did not have a very good performance during the last 90 trading days. Equity ratings for Diamyd Medical AB are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 21st of March 2024 and ending today, the 20th of April 2024. Click here to learn more.
Diamyd Medical AB , a diabetes company, engages in the development of combination therapies for the treatment of autoimmune diabetes. The company was formerly known as Diamyd Therapeutics AB and changed its name to Diamyd Medical AB in April 2013. Diamyd Medical operates under Biotechnology classification in Sweden and is traded on Stockholm Stock Exchange. The company has 76.93 M outstanding shares. More on Diamyd Medical AB
Moving against Diamyd Stock
| 0.56 | CAMX | Camurus AB | PairCorr |
| 0.43 | GENO | Genovis AB | PairCorr |
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Diamyd Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Diamyd Medical's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Diamyd Medical or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
Diamyd Medical AB (DMYD-B) is traded on Stockholm Exchange in Sweden and employs 20 people. The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.21 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Diamyd Medical's market, we take the total number of its shares issued and multiply it by Diamyd Medical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Diamyd Medical AB operates under Healthcare sector and is part of Biotechnology industry. The entity has 76.93 M outstanding shares.
Diamyd Medical AB has accumulated about 119.76 M in cash with (93.22 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.02.
Check Diamyd Medical Probability Of Bankruptcy
Ownership AllocationDiamyd Medical holds a total of 76.93 Million outstanding shares. Diamyd Medical AB retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Diamyd Ownership Details
Diamyd Stock Price Odds Analysis
What are Diamyd Medical's target price odds to finish over the current price? Depending on a normal probability distribution, the odds of Diamyd Medical jumping above the current price in 90 days from now is about 68.67%. The Diamyd Medical AB probability density function shows the probability of Diamyd Medical stock to fall within a particular range of prices over 90 days. Assuming the 90 days trading horizon Diamyd Medical AB has a beta of -0.1242 suggesting as returns on the benchmark increase, returns on holding Diamyd Medical are expected to decrease at a much lower rate. During a bear market, however, Diamyd Medical AB is likely to outperform the market. Additionally, diamyd Medical AB has an alpha of 0.4937, implying that it can generate a 0.49 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
Based on a normal probability distribution, the odds of Diamyd Medical to move above the current price in 90 days from now is about 68.67 (This Diamyd Medical AB probability density function shows the probability of Diamyd Stock to fall within a particular range of prices over 90 days) .
Diamyd Medical AB Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Diamyd Medical market risk premium is the additional return an investor will receive from holding Diamyd Medical long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Diamyd Medical. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Diamyd Medical's alpha and beta are two of the key measurements used to evaluate Diamyd Medical's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 4.2 | |||
| Semi Deviation | 5.51 | |||
| Standard Deviation | 6.54 | |||
| Variance | 42.74 |
Diamyd Stock Against Markets
Picking the right benchmark for Diamyd Medical stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Diamyd Medical stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Diamyd Medical is critical whether you are bullish or bearish towards Diamyd Medical AB at a given time. Please also check how Diamyd Medical's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Diamyd Medical without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Volatility Analysis Now
Volatility AnalysisGet historical volatility and risk analysis based on latest market data |
| All Next | Launch Module |
Diamyd Medical Corporate Management
Elected by the shareholders, the Diamyd Medical's board of directors comprises two types of representatives: Diamyd Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Diamyd. The board's role is to monitor Diamyd Medical's management team and ensure that shareholders' interests are well served. Diamyd Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Diamyd Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Ulf MBA | CEO Pres | Profile | |
| Anton Lindqvist | Chief Officer | Profile | |
| Martina Widman | Chief Officer | Profile | |
| Anna BSc | Chief Officer | Profile | |
| Christoph Nowak | Chief Officer | Profile | |
| Eva Karlstrom | Chief Officer | Profile |
How to buy Diamyd Stock?
Before investing in Diamyd Medical, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Diamyd Medical. To buy Diamyd Medical stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Diamyd Medical. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Diamyd Medical stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Diamyd Medical AB stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Diamyd Medical AB stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Diamyd Medical AB, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments.
Already Invested in Diamyd Medical AB?
The danger of trading Diamyd Medical AB is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Diamyd Medical is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Diamyd Medical. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Diamyd Medical AB is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Diamyd Medical AB. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Complementary Tools for Diamyd Stock analysis
When running Diamyd Medical's price analysis, check to measure Diamyd Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Diamyd Medical is operating at the current time. Most of Diamyd Medical's value examination focuses on studying past and present price action to predict the probability of Diamyd Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Diamyd Medical's price. Additionally, you may evaluate how the addition of Diamyd Medical to your portfolios can decrease your overall portfolio volatility.
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |